RIP
BMY icon

Reliant Investment Partners’s Bristol-Myers Squibb BMY Stock Holding History

Reliant Investment Partners’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$212K Sell
3,671
-100
-3% -$5.74K 0.14% 121
2026
Q1 		$229K Hold
3,771
– – 0.19% 102
2025
Q4 		$203K Buy
+3,771
New +$181K 0.16% 105
2025
Q2 		– Sell
-3,771
Closed -$230K – 112
2025
Q1 		$230K Buy
3,771
+90
+2% +$5.25K 0.23% 85
2024
Q4 		$208K Buy
+3,681
New +$206K 0.18% 107

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Reliant Investment Partners's BMY Position: Q2 2026 in Review

Reliant Investment Partners reduced its Bristol-Myers Squibb (BMY) stake by 2.7% in Q2 2026, selling an estimated $5.74K and leaving 3,671 shares worth $212K. The position accounts for 0.14% of the portfolio, ranked #121.

Reliant Investment Partners first reported a position in BMY in Q4 2024 and has held it in 5 quarters since. The position peaked at $230K in Q1 2025. 2,526 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Reliant Investment Partners held 3,671 shares of Bristol-Myers Squibb worth $212K as of Q2 2026.
  • Reliant Investment Partners sold 100 Bristol-Myers Squibb shares in Q2 2026, an estimated $5.74K.
  • Bristol-Myers Squibb made up 0.14% of Reliant Investment Partners's portfolio in Q2 2026, its #121 holding.
  • Reliant Investment Partners first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 5 quarters since.
  • Reliant Investment Partners's Bristol-Myers Squibb position peaked at $230K in Q1 2025.
  • 2,526 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Reliant Investment Partners's 13F filing for Q2 2026, filed 11 Aug 2026.